tirzepatide cvot trial In the SURPASS-CVOT head-to-head trial involving over 13,000 adults with T2D and ASCVD, tirzepatide (Mounjaro) matched dulaglutide in reducing major cardiovascular events (8% lower risk) and significantly cut all-cause mortality by 16%

A woman in her 30s presented w a 1 week hx of a pruritic rash that began in the B L axillae after her third weekly dose of tirzepatide (Zepbound) & subsequently involved the Contrave: How It Works, How to Take It, and Side Effects Oral Semaglutide Liquid Drops BloomMD Production GLP 1s for Small Amounts of Weight Loss? Doctors Say Yes Does Ozempic Make Food Taste Different? How It Quiets Cravings 3 Month Micro dosing Tirzepatide Feel Fuller Longer with WeightCare